Sort
82,697 grants matching “vaccine development”
Population-based Approach to Malaria Research and Control
$1,489,336Donald J. Krogstad · Tulane University Of Louisiana · U19 · FY2013 · AI
Live Attenuated RSV Vaccine with Optimized Safety and Immunogenicity
$1,489,165Mark E. Peeples · Research Inst Nationwide Children'S Hosp · P01 · FY2016 · AI
Heterodimeric IL-15 in Cancer Immunotherapy
$1,489,039George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Live Attenuated RSV Vaccine with Optimized Safety and Immunogenicity
$1,488,538Mark E. Peeples · Research Inst Nationwide Children'S Hosp · P01 · FY2018 · AI
Adoptive Cell Transfer Immunotherapy of Cancer
$1,488,319Steven Rosenberg · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Development of a Novel CEA Expressing Ad5 [E1-, E2b-] Vector for Treatment
$1,488,231Frank R. Jones · Etubics Corporation · R44 · FY2009 · CA
Development of an H2O2-Inactivated Dengue Virus Vaccine
$1,488,158Mark K Slifka · Oregon Health & Science University · R01 · FY2014 · AI
Flavivirus Infections: Pathogenesis and Prevention
$1,488,134Francis Anthony Ennis · Univ Of Massachusetts Med Sch Worcester · P01 · FY2006 · AI
NIH Tetramer Core Facility
$1,487,872John Altman · Emory University · N01 · FY2023 · AI
Molecular Mechanisms Of Synaptic Transmission
$1,487,809David Robinson · National Institute On Deafness And Other Communication Disorders · ZIA · FY2011 · DC
Live Attenuated RSV Vaccine with Optimized Safety and Immunogenicity
$1,487,635Mark E. Peeples · Research Inst Nationwide Children'S Hosp · P01 · FY2017 · AI
Interplay of B cells and HIV Leading to Broad Neutralizing Antibody Responses
$1,487,455Pascal Poignard · International Aids Vaccine Initiative · U19 · FY2014 · AI
The Miami Center for AIDS Research
$1,487,266Savita Pahwa · University Of Miami School Of Medicine · P30 · FY2015 · AI
EMORY/ATLANTA CENTER FOR AIDS RESEARCH(CFAR)
$1,487,156Emory University · P30 · FY2004 · AI
A single-dose prophylactic Japanese Encephalitis vaccine
$1,486,847Eszter Nagy · Valneva Austria Gmbh · U01 · FY2007 · AI
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
$1,486,778James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Maintenance of an SPF Macaque Breeding Colony for AIDS Research
$1,486,592Kasi E Russell-Lodrigue · Tulane University Of Louisiana · U42 · FY2025 · OD
Mali International Center for Excellence in Research: Malaria Clinical Research
$1,486,314Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Midwest STIs Topical Microbicide Cooperative Research
$1,486,128Stanley M Spinola · Indiana Univ-Purdue Univ At Indianapolis · U19 · FY2006 · AI
North Carolina STI/TM Cooperative Research Center
$1,485,500University Of North Carolina Chapel Hill · U19 · FY2004 · AI
Pathogenesis of Tick-Borne Flavivirus Infections
$1,485,371Marshall Bloom · Niaid Extramural Activities · Z01 · FY2007 · AI
Defining Factors Controlling HIV Rebound
$1,485,132Jerome A. Zack · University Of California Los Angeles · P01 · FY2020 · AI
Anthrax Immune Globulin to Prevent & Treat Anthrax: Advanced Product Development
$1,485,126Ajoy Chakrabarti · Emergent Product Development Gaithersbur · U01 · FY2007 · AI
Viral and Host Determinants of Infant and Childhood Allergy and Asthma
$1,485,056Ray Stokes Peebles · Vanderbilt University Medical Center · U19 · FY2018 · AI
Laboratory And Pre-clinical Studies Of Parainfluenza Viruses
$1,484,945Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI